Yucca Health Review 2026: Compounded GLP-1 Audit

At a glance

Yucca Health holds a 4.6-star Trustpilot rating across ~1,000 reviews as of 2026, in a category where most providers sit between 50 and 300 reviews.
Two programs: Semaglutide+ (from $206/mo on the 6-month plan) and Tirzepatide+ (from $325/mo on the 6-month plan), both with B12 added.
Compounded by US FDA-registered pharmacies and prescribed by US-licensed clinicians, available in all 50 states. Compounded GLP-1 is not FDA-approved.
Standard process: 24-hour async eligibility review, ships in 2-4 days, no membership fees, includes onboarding provider call.
Underlying drug efficacy is well-characterized: 14.9% (STEP-1 semaglutide), 22.5% (SURMOUNT-1 tirzepatide), with tirzepatide winning the head-to-head SURMOUNT-5.

4.6 stars. ~1,000 Trustpilot reviews. That is a hard combination to fake.

Most telehealth GLP-1 providers in the compounded-medication space hover between 50 and 300 Trustpilot reviews. Holding a 4.6 average across nearly a thousand of them takes either a real operations team or a long-running review-manipulation program, and the texture of Yucca's reviews (named providers, specific shipping windows, identifiable products) reads like the former.

We have covered the research-vial path through Ascension Peptides extensively. This article covers the other path: the US-clinician prescription route for compounded GLP-1, and whether Yucca Health is the right place to take it.

Bottom line: If you want a US-licensed clinician to prescribe compounded Tirzepatide or Semaglutide and have it shipped to your door without a membership fee, Yucca is the option we cite first. Its rating across a meaningful review sample is the differentiator.

Who Yucca is for (and who it is not)

Yucca Health is a US-based telehealth platform that connects patients with US-licensed clinicians and ships compounded GLP-1 medications through partner FDA-registered compounding pharmacies. Available in all 50 states.

It is built for one specific user:

You want a prescription, not a research vial
You want a clinician relationship, even if it is asynchronous
You want the medication shipped, not picked up at a pharmacy
You do not want a recurring membership fee
You want the option to pay across 3 or 6 months instead of monthly

If you are buying research-grade peptides for off-label or research use, Yucca is not the right path. That audience belongs at Ascension Peptides. If you want brand-name Ozempic, Wegovy, Mounjaro, or Zepbound under your insurance, Yucca is also not the right path. You want your primary care doctor or your endocrinologist running the prior-authorization process. Yucca is for the middle path: compounded, US-clinician-prescribed, cash-pay or buy-now-pay-later, shipped.

What Yucca actually prescribes

Yucca offers two programs, both compounded by FDA-registered US pharmacies and both formulated with an added B12 boost (which is the "+" in the product names).

Semaglutide+ is compounded semaglutide, the same active molecule as Wegovy and Ozempic, plus B12. Semaglutide is the GLP-1 receptor agonist most weight-loss literature is built on. The Phase 3 STEP-1 trial in 1,961 adults with obesity produced a mean 14.9% body weight reduction at 68 weeks (Wilding et al. NEJM 2021, PMID 33567185).

Tirzepatide+ is compounded tirzepatide, the same active molecule as Zepbound and Mounjaro, plus B12. Tirzepatide is a dual GIP / GLP-1 agonist and is the deeper-weight-loss option of the two. The Phase 3 SURMOUNT-1 trial in 2,539 adults with obesity produced a mean 22.5% body weight reduction at 72 weeks at the 15 mg dose (Jastreboff et al. NEJM 2022, PMID 35658024).

The two drugs went head-to-head in SURMOUNT-5, a 751-patient randomized trial run by Eli Lilly. Tirzepatide produced 20.9% mean weight loss vs 13.7% for semaglutide at 72 weeks (Aronne et al. NEJM 2025, PMID 40353578). For a deeper read on the head-to-head numbers, see our SURMOUNT-5 evidence breakdown.

What this means for Yucca: if you can tolerate tirzepatide, the data favors it. If you cannot, semaglutide remains a clinically meaningful option and is around 35 to 40 percent cheaper at Yucca's pricing.

Pricing at Yucca: what you actually pay

The cleanest way to read Yucca's pricing is by plan length, not by monthly. The 6-month plan is the lowest per-month rate. Both products offer additional first-month discounts.

Plan	Semaglutide+	Tirzepatide+
Monthly	$275/mo	$385/mo
3-month	$255/mo	$355/mo
6-month	$206/mo	$325/mo
First-month promo (low end)	~$175	~$258

Other costs to know:

No membership fee. You pay only for the medication and the program
B12 boost is included in every formulation
Onboarding provider call is included
Klarna, Affirm, and Afterpay financing available on the 6-month plans
Shipping is included (US-based, 2 to 4 days)

For context, Hims charges around $279 for compounded semaglutide monthly and Ro charges around $349 monthly. Yucca's 6-month Semaglutide+ at $206/mo is competitive on price, especially with the B12 included. Yucca's 6-month Tirzepatide+ at $325/mo is in the middle of the compounded-tirzepatide market.

If cost is the dealbreaker, the 6-month plan is the most defensible commitment. Both GLP-1 drugs have a multi-month titration before the maintenance dose, so 6 months of continuity matters clinically too. Stopping early often leads to weight regain, particularly with semaglutide where the rebound after discontinuation is well-documented.

Bottom line: The Yucca pricing model rewards commitment. Monthly is expensive. The 6-month plan is where the math works.

The patient process: intake, review, ship

The flow is the same telehealth pattern most cash-pay GLP-1 providers use, with a few specific Yucca details:

Online intake form. Weight goals, medical history, current conditions, prior weight-loss treatments. Typically 10 to 15 minutes.
Clinician async review within 24 hours. A US-licensed clinician reviews your intake and either approves a starting dose or comes back with follow-up questions.
Optional onboarding call. Included with the plan. Not required for prescription but useful if you have specific questions about titration, side effects, or the rebound question.
Prescription routed to compounding pharmacy. FDA-registered, US-based.
Ships in 2 to 4 days. Refrigerated shipping for semaglutide and tirzepatide.

The Trustpilot themes that come up consistently:

Speed. Approval and shipping are reliably faster than the 24-hour and 4-day windows quoted on the site.
Provider responsiveness. Patients message back and forth with the clinician through the portal. Replies generally come within hours, not days.
Onboarding quality. The pre-treatment call gets explicit positive mentions. This is the most labor-intensive thing Yucca does and the one most cash-pay competitors skip.
Adjustment periods. The most common criticism is the GI side effect window during titration. Yucca does not cause this. The drugs do. The complaint is real but is a property of GLP-1 therapy, not of Yucca specifically.
Payment friction. A small number of negative reviews involve subscription cancellation or billing edge cases. These are operational and resolvable.

The compounded-GLP-1 caveat (read this)

Compounded GLP-1 medications are not FDA-approved. They are prepared by FDA-registered compounding pharmacies operating under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.

The FDA's enforcement posture on compounded GLP-1 has shifted multiple times during the brand-name shortage of 2024 to 2025. As of 2026, with brand-name Wegovy and Zepbound off the FDA shortage list, the legal basis for compounded versions narrowed. Compounding pharmacies can still produce these medications when:

A clinician documents medical necessity that the FDA-approved version cannot meet (dosing, ingredients, allergies)
The patient has a documented adverse reaction or intolerance to a brand-name component
The clinician documents the rationale on a per-patient basis

Yucca's clinicians handle this documentation. The legal question is real but is not specific to Yucca. If you want zero ambiguity, the only fully unambiguous path is brand-name medication through traditional pharmacy channels. Compounded carries policy and quality variability that brand-name does not.

Warning: Compounded GLP-1 is legal under specific clinical conditions but is not FDA-approved. The FDA does not perform pre-market review of compounded preparations. Quality varies by compounding pharmacy. Yucca's pharmacy partners are FDA-registered, which is the strongest signal available, but is not equivalent to brand-name oversight.

Who should not use compounded GLP-1 through Yucca or anyone else:

Personal or family history of medullary thyroid carcinoma or MEN 2
Active pancreatitis or known severe gallbladder disease
Pregnant or breastfeeding
Type 1 diabetes without specific clinical oversight
Severe gastroparesis

Yucca's intake form screens for these. The screening is not a substitute for your own knowledge of your medical history.

How Yucca sits in the compounded-GLP-1 market

The cash-pay compounded GLP-1 space in 2026 is crowded. Hims, Ro, Mochi, Eden, Henry Meds, and a long tail of smaller telehealth providers all offer some version of the same product: compounded semaglutide or tirzepatide, US-clinician prescription, shipped to the door.

Most of them cluster in the same pricing band for the lowest plan tier:

Compounded semaglutide commitment plans generally land between $206 and $350 per month at lowest tier
Compounded tirzepatide commitment plans generally land between $325 and $500 per month at lowest tier
A subset charge an additional membership or platform fee on top

Yucca sits at the lower end of both pricing bands without a membership fee. Its Semaglutide+ 6-month plan at $206/mo is among the most aggressive prices in the non-membership category. Tirzepatide+ at $325/mo is mid-pack.

The price comparison is one input. The other is review sample size and rating. Most compounded-GLP-1 providers have fewer than 500 Trustpilot reviews. Yucca's ~1,000-review sample at a 4.6-star average is unusual in the category. The largest brand-name telehealth platforms have larger samples but generally lower averages.

Translation: if you are filtering for the cheapest cash-pay compounded GLP-1 with a real review track record at scale, Yucca is the option to start with. Confirm current pricing on the provider's site at the time of purchase since the market moves monthly.

Where Yucca falls short

In the spirit of an honest audit:

Brand-name access is missing. Yucca does not handle brand-name Ozempic, Wegovy, Mounjaro, or Zepbound through insurance. That requires your primary care doctor or a different telehealth provider with insurance contracting.
No physical clinic. Everything is async or telehealth. If you want an in-person visit, weigh-in, body composition scan, or in-clinic injections, Yucca cannot do that.
Pricing is still meaningful. $206 to $325/mo on the 6-month plan is real money. Buy-now-pay-later does not make it cheaper, just easier to absorb.
GI side effects are not Yucca's fault but are real. Nausea, vomiting, constipation are common during titration. The onboarding call addresses this but cannot prevent it.
The legal frame around compounded GLP-1 remains in motion. If the FDA's enforcement posture changes again, the compounded path may narrow or shift.

If you fit the profile (US resident, want a prescription, can tolerate the cost, do not need brand-name through insurance), Yucca Health is our first recommendation in the compounded GLP-1 telehealth category. The combination of:

Real Trustpilot data at scale
US-licensed clinicians and FDA-registered pharmacies
Included B12 and onboarding call
No membership fee
Klarna / Affirm / Afterpay financing on 6-month plans

is the cleanest version of the cash-pay GLP-1 path we have seen, and the 4.6 rating across nearly 1,000 reviews is the part we cannot reproduce with copy.

FAQ

Is Yucca Health legit?

Yes. Yucca Health is a US-based telehealth platform that connects patients with US-licensed clinicians and ships compounded medications from FDA-registered compounding pharmacies. The platform is available in all 50 states. Its 4.6-star Trustpilot rating across nearly 1,000 reviews is meaningful corroboration at sample size.

Is compounded GLP-1 the same as Ozempic or Wegovy?

The active ingredient is the same molecule. The formulation is different (compounded versions add B12 and may use different inactive ingredients), and the regulatory pathway is different. Compounded medications are not FDA-approved. They are prepared by FDA-registered pharmacies on a per-patient basis under specific clinical conditions. The pharmacology of the active molecule is identical to the brand-name version.

How fast does Yucca actually ship?

Quoted at 2 to 4 days. Trustpilot patient reports consistently come in at or under that window for US destinations. Refrigerated shipping for both semaglutide and tirzepatide.

Can I cancel the 6-month plan early?

Yes. Yucca's policy allows cancellation, though refund mechanics vary by plan. The recurring complaint pattern in negative reviews involves billing edge cases around cancellation. Read the terms on the 6-month plan before committing if you are unsure about long-term tolerability.

What if I have a bad reaction during titration?

Yucca's clinicians can adjust dose, slow titration, or pause treatment. Message the provider through the portal. The asynchronous turnaround is typically same-day. For severe reactions (suspected pancreatitis, severe abdominal pain, persistent vomiting), seek in-person medical care immediately and notify Yucca afterward.

Is Yucca better than the bigger telehealth platforms?

It depends on what you optimize for. The large platforms have brand recognition, broader treatment menus beyond GLP-1, and existing membership infrastructure. Yucca has tighter pricing at the 6-month tier, no membership fee, and an unusually clean Trustpilot rating at meaningful sample size. If GLP-1 is the only product you care about and you want a low-friction cash-pay path with a real review profile, Yucca is the option we cite first.

What if compounded GLP-1 gets banned?

If the FDA's enforcement posture changes, Yucca and every other compounded-GLP-1 provider would need to pivot. The drugs are not inherently illegal; the path of access through compounding is governed by FDA discretion plus state pharmacy boards. As of 2026 the path remains open for clinically-documented use. We will update this article if that changes.

Does Yucca prescribe retatrutide?

No. Retatrutide is not FDA-approved and is still in Phase 3. The compounded GLP-1 telehealth pathway does not apply. If retatrutide receives FDA approval, expect Yucca and competitors to add it to their offerings within months. For now, retatrutide is research-only. See our retatrutide TRIUMPH-1 Phase 3 article for the latest data.

Get started with Yucca Health

If the prescription path fits your situation, Yucca Health is where we send readers. Personalized Semaglutide+ from $206/mo on the 6-month plan. Tirzepatide+ from $325/mo on the 6-month plan. US-licensed clinicians, FDA-registered compounding pharmacies, available in all 50 states, ships in 2 to 4 days.

If you prefer the research-grade vial path instead, our Ascension Peptides review 2026 covers the alternative.

This article is for educational and informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Yucca Health is a sponsor of Peptides:Enhanced through an affiliate relationship; we earn a referral commission if you qualify. Compounded GLP-1 medications are not FDA-approved and are prepared by FDA-registered compounding pharmacies under specific clinical conditions. The legal status of compounded GLP-1 medications may change depending on FDA enforcement posture and drug shortage status. Pricing, plan terms, and patient ratings are accurate as of May 2026 and may change. Always consult a qualified clinician before starting any GLP-1 medication.

Tagsyucca-healthyucca-health-reviewglp-1telehealthprescriptiontirzepatidesemaglutidecompounded-glp-1weight-lossvendor-review2026-vendor-guide